Spontaneous Formation and Rearrangement of Artificial Lipid Nanotube Networks as a Bottom-Up Model for Endoplasmic Reticulum

Summary

Solid-supported, protein-free, double phospholipid bilayer membranes (DLBM) can be transformed into complex and dynamic lipid nanotube networks and can serve as 2D bottom-up models of the endoplasmic reticulum.

Abstract

We present a convenient method to form a bottom-up structural organelle model for the endoplasmic reticulum (ER). The model consists of highly dense lipidic nanotubes that are, in terms of morphology and dynamics, reminiscent of ER. The networks are derived from phospholipid double bilayer membrane patches adhering to a transparent Al₂O₃ substrate. The adhesion is mediated by Ca²⁺ in the ambient buffer. Subsequent depletion of Ca²⁺ by means of BAPTA/EDTA causes retraction of the membrane, resulting in spontaneous lipid nanotube network formation. The method only comprises phospholipids and microfabricated surfaces for simple formation of an ER model and does not require the addition of proteins or chemical energy (e.g., GTP or ATP). In contrast to the 3D morphology of the cellular endoplasmic reticulum, the model is two-dimensional (albeit the nanotube dimensions, geometry, structure, and dynamics are maintained). This unique in vitro ER model consists of only a few components, is easy to construct, and can be observed under a light microscope. The resulting structure can be further decorated for additional functionality, such as the addition of ER-associated proteins or particles to study transport phenomena among the tubes. The artificial networks described here are suitable structural models for the cellular ER, whose unique characteristic morphology has been shown to be related to its biological function, whereas details regarding formation of the tubular domain and rearrangements within are still not completely understood. We note that this method uses Al₂O₃ thin-film-coated microscopy coverslips, which are commercially available but require special orders. Therefore, it is advisable to have access to a microfabrication facility for preparation.

Introduction

The ER carries out crucial tasks in the biological cell including protein folding, lipid synthesis, and calcium regulation^1,2. The ER morphology is intrinsic to the functions it performs. It combines planar stacks and dense-dynamic tubular domains, which continuously interact with the cytoskeleton and undergo constant motion and rearrangement. Some of the remodeling that ER structures undergo include the continuous transformation between planar sheets and tubes, vesicle formation from or fusion to the ER lumen, elongation of pre-existing tubes, tube retraction, fusion, and breakage³. The peculiar structure of the tubular networks is energetically unfavorable. The pathways and mechanisms by which the ER generates and maintains this organization as well as how this relates to its function is not yet fully understood^4,5.

It is known that the ER malfunctions when it loses its homeostatic state, resulting in ER stress, a condition caused by an increase in protein synthesis, accumulation of misfolded proteins, or changes in Ca²⁺ and oxidative balance. ER stress in turn causes deformation of the natural morphology of the organelle, specifically by disturbing the network organization^6,7. As a response, the cell activates a repair mechanism to return to a homeostatic state. Failure in repair can lead to ER-induced cell apoptosis, which contributes to several metabolic and degenerative diseases such as Alzheimer's disease, type 2 diabetes, Parkinson's disease, amyotrophic lateral sclerosis, and several others^7,8. Current research targets the organization of the tubular ER networks, and several studies are focusing on reconstituting the ER in vitro². A few existing models^2,9,10 require proteins to initiate and maintain membrane curvature^3,11 and help the organelle reach its shape. Clearly, model systems that mirror some of the key structural and organizational features of the ER and provide access to advanced experimental studies are in great demand.

We present here procedures for the preparation of a facile, protein/chemical energy-free, dynamic in vitro model for the ER, providing a basic platform to study ER morphology and associated functions⁴. In this method, an ER model is fabricated with a bottom-up approach using only a few elements, in which the molecules of interest can be integrated to add complexity. The network represents ER structure and dynamics. Furthermore, reversible transformation between the planar membrane and the tubes, vesicle formation from the tubes, tube fusion, sliding and retraction can all be observed. In addition to serving as a bottom-up model for the incompletely understood cellular ER, the lipid route to nanotube networks described in this protocol can be applicable for researchers studying self-assembly, nanofluidics, single-molecule and colloid transport phenomena, Marangoni flow, and other related fields. The only molecular building blocks used in our method are phospholipids. The protocol requires little laboratory work and basic equipment and is accessible for the incorporation of additional elements.

Protocol

1. Preparation of Phospholipid Vesicle Suspension

NOTE: For all materials referred to as "clean" in this protocol, thoroughly wash them with isopropanol followed by deionized water and blow-dry them with nitrogen. Note that a treatment of glass substrates with strongly oxidizing acidic agents (Piranha solution), which is typically applied in preparation protocols for supported lipid films on solid substrates, should not be performed on Al₂O₃-coated carriers.

1. Place in a clean 10 mL round-bottom or inverted pear-shaped glass flask: Soy L-α phosphatidyl choline (PC, 69% w/w), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE, 30% w/w), and a lipid-conjugated fluorophore of choice [e.g., Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (TR-DHPE, 1% w/w)] in chloroform; for a total amount of 3000 µg of lipids in 300 µL of chloroform, resulting in a final concentration of 10 mg/mL.
   NOTE: Use clean, glass, gas-tight syringes with polytetrafluoroethylene plungers when handling compounds containing chloroform.
   CAUTION: Chloroform is toxic and highly volatile and should always be handled under a fume hood with associated personal protective equipment.
2. Connect the flask to a rotary evaporator, position with a tilt of 45°, and rotate at 24 rpm inside a water bath at 23 °C for 6 h with reduced air pressure to slowly and completely remove the chloroform. Start reducing the pressure right after initiating the rotation by steps of 20 kPa every 2 min until it reaches 20 kPa (150 Torr, 80% vacuum).
   NOTE: The formation of a homogenous lipid film of uniform thickness in the preparation vessel is the most important requirement for the rotavap procedure. Lipid preparations are sensitive to rotation velocity, rapid pressure changes, and final pressure value; therefore, strictly follow the slow reduction steps as well as the end pressure and rotation velocity. Position the flask with a tilt of 45° to guarantee that the dehydrated lipid cake is formed evenly as a film on the wall of the flask. Too fast of a rotation leads to turbulences and too slow of a rotation leads (due to gravity) to the accumulation of a thick layer of fluid at the bottom of the flask. During the subsequent overnight swelling process, a very inhomogenous lipid mass is produced that does not respond well to the final sonication step, and the resulting fractions are of different compositions. Pressure and time within the range specified in the method ensures slow desolvation. With chloroform as the solvent, too rapid of a drop in pressure cools down the mixture, resulting in increased viscosity and aggregate and uneven film formation. The long time period of 6 h is recommended in order to remove solvent to the greatest extent possible, as the organic solvent partitions into the lipid material upon rehydration.
3. After 6 h, stop the rotation and increase the air pressure again, gradually, by steps of 20 kPa every 2 min until reaching 100 kPa. Remove the flask from the rotary evaporator and add 3 mL of PBS and 30 µL of glycerol. Gently swirl the flask to dissolve the glycerol. Use an air-tight glass stopper to seal the flask containing the lipids.
   NOTE: The glycerol is used to prevent the complete dehydration of the lipid film and enables bilayer separation¹². It should be heated before use to decrease its viscosity, which facilitates the handling of this compound. The warmed glycerol does still not immediately mix with the PBS buffer. Gentle swirling is required until the glycerol is completely dissolved.
4. Store the flask in the refrigerator at 4 °C overnight for rehydration and swelling of the lipid films.
5. On the following day, sonicate the lipids with an ultrasonic water bath at room temperature (RT, ~21 °C) and at 35 kHz frequency until achieving a uniform, slightly turbid lipid suspension.
   NOTE: Sonication can take around 10-30 s. Prolonged sonication (~1 min) produces heat and is detrimental to vesicle formation.
6. Steps 1.1-1.5 yield a suspension containing two types of vesicular structures: multilamellar vesicles (MLV) and giant unilamellar vesicles (GUV) (Figure 1A-1F).
7. For storage, divide the lipid suspension into 100 µL aliquots, using a total of 30 microcentrifuge tubes, and store them in a freezer at -20 °C.
   NOTE: Flash freezing with liquid nitrogen is not necessary and not used before storage. The protocol can be paused here. Leaving lipid suspensions in the 4 °C refrigerator for prolonged times causes lipid lysis, which affects the membrane composition.

2. Preparation of Substrates

NOTE: The following protocol is performed at a cleanroom classified as ISO 8 in the ISO 14644-1 standard specification. Atomic layer deposition (ALD) is used to fabricate Al₂O₃ substrates. The specified process parameters are instrument-dependent and may vary between different models of equipment. They can be used as initial parameters to develop the process.

1. Set the temperature of the ALD reactor to 200 °C.
2. Load the glass surfaces (e.g., glass coverslips) into the sample chamber together with a silicon wafer, which will be used later as a reference surface to determine thickness of the deposition by ellipsometry.
   NOTE: Glass substrates were used out-of-the-box and were not solvent-cleaned before deposition. They were only flushed with nitrogen gas to remove particles.
3. Evacuate the loading chamber to 400 Pa (3 torr) and transfer the samples into the main reaction chamber, and evacuate it to 200 Pa.
   NOTE: The temperature of the reactor must be maintained at 200 °C for proper deposition. Temperature fluctuations after sample loading must therefore be equilibrated before initiating the deposition. Chamber pressure is set to be higher than reactor pressure to avoid any precursors to spread outside the chamber.
4. Start depositing the atomic film. One cycle consists of a 150 ms pulse trimethyl aluminum exposure, followed by a 1 s purge, and subsequently, a H₂O exposure of 200 ms duration followed by a 1 s purge.
   NOTE: All settings including chamber and reactor pressure, length of the cycles, and purges are automated to achieve a defined rate of deposition. These parameters may vary among the various models of equipment. The pre-configured recipes are often prepared by the vendor or tool responsible in the clean room and communicated to the user as deposited film thickness per unit of time.
5. To reach 10 nm of Al₂O₃ on the substrate, repeat the process for 100 cycles. The number of cycles depends on the deposition rate, which may vary among different recipes or equipment.
6. To remove the samples from the reactor, first vent the chamber until its pressure reaches atmospheric pressure, then remove the samples.
7. Store the samples in air tight containers at RT until use.
   NOTE: No further cleaning is recommended before use. The protocol can be paused here.
   NOTE: The samples should ideally be used immediately after deposition. The optimal storage requires positioning the surfaces inside polypropylene wafer carriers, followed by enveloping the carriers in clean room-compatible plastic bags, which are to be nitrogen-flushed before vacuum sealing. The purpose is to avoid exposing the surface to air-borne contaminants. If necessary, the surfaces can be kept in air tight containers at RT at maximum for 5 days. Longer storage is not recommended. For users who do not have easy access to a clean room nearby, and purchase or obtain the surfaces from abroad, re-oxidizing the substrates by means of oxygen plasma or ozone treatment may be an alternative solution¹³.

3. Transformation of Molecular Phospholipid Films to Tubular Networks

1. Thaw the lipid suspension and transfer a 4 µL droplet of suspension onto a clean glass microscope slide/coverslip.
2. Desiccate the droplet for 20 min. The droplet will collapse into a flat circular film of lipids after desiccation, which is visible to the eye.
3. Rehydrate the lipid film with 1 mL of HEPES buffer (see Table of Materials) for 3 min.
   NOTE: The volume of rehydration buffer affects the density of vesicle suspension (the number of vesicles per unit volume), which is subsequently transferred to the observation chamber. Depending on the volume of the observation chamber and the desired vesicle density, the rehydration volume can be tuned to 0.5-1 mL. Clean borosilicate slides tend to support droplets of several hundred microliters up to 1.5 mL without problems. Since the coverslip does not need to be moved, this does not lead to a technical problem. On more hydrophobic surfaces, such as SU-8 polymer-coated slides, even 1.5 mL can be deposited¹².
   NOTE: Lipids should be freshly prepared, as exposure of the rehydrated lipid film for more than 20 min at RT leads to evaporation of the buffer and partial dehydration of the previously rehydrated vesicles, which leads to a poorly defined composition.
4. Prepare the observation chamber: to allow for buffer exchange by means of an automatic pipette, which is required to initiate the ER transformation, an observation chamber with an open top was used. This chamber consists of a polydimethylsiloxane (PDMS) frame with dimensions 1.5 x 1.5 x 0.5 cm, adhered onto the Al₂O₃ deposited coverslip. A scheme of the mounted observation chamber is represented in Figure 1G. The following steps were performed to fabricate the PDMS frame and assemble the observation chamber:
   1. Prepare a KOH solution by mixing 100 g of KOH with 100 mL of isopropanol in a beaker in an ice bath. Stir for 10 h or longer until the KOH is completely dissolved using a magnetic stirrer and magnetic stir plate.
      CAUTION: KOH solution is corrosive and can lead to skin burns, so always handle with proper personal protective equipment.
      NOTE: The solubility of KOH in isopropanol is not as high as in water. The dissolution is exothermic. Crushing the KOH pellets prior to dissolving and continuous stirring is advisable.
   2. Submerge a glass Petri dish (d = 6 cm) into the KOH solution at RT and keep it overnight.
   3. The following day, remove the glass dish from the solution, immerse it in a container with deionized water for 5 min, rinse it several times with water, and place it inside a drying oven at 80 °C for 1 h. Blow the surface briefly with a stream of nitrogen to ensure that particles are removed.
   4. To passivate the surface and prevent bonding to PDMS, transfer 200 µL of dimethyldichlorosilane with a plastic syringe into a clean plastic container such as a weighting boat.
   5. Store the glass Petri dish together with the silane for 1 h in an evacuated desiccator (low vacuum, ~20 kPa).
      CAUTION: Dimethyldichlorosilane is toxic and should always be handled under a fume hood with associated personal protective equipment.
   6. Wait 15 min before collecting the Petri dish in order for the remaining dimethyldichlorosilane vapor to dissipate. The Petri dish is now silanized, and the surface is hydrophobic.
      NOTE: A quick way to test the success of this step is to place a water droplet onto the silanized Petri dish. The contact angle of the droplet with the surface must visibly increase compared to untreated glass.
   7. In a 250 mL plastic container (transparent plastic cup fresh from the package), mix 10 g of silicone elastomer base with 1 g of silicone elastomer curing agent (10:1). Stir using a plastic stirrer/plastic spatula for 5 min.
      NOTE: Air bubbles are formed upon stirring, and the PDMS will look pale-white.
   8. Desiccate the mixture to degas at < 20 kPa until all expanding air bubbles have collapsed (higher vacuum accelerates the process). Pour the degassed mixture into the silanized Petri dish.
   9. Cure at 65 °C for 2 h in an oven.
      NOTE: It is possible to double the curing speed by increasing the temperature to > 95 °C. The increasing curing temperature results in an increase in stiffness of the material.
   10. Cool down the Petri dish filled with the cured PDMS to RT and remove the PDMS slab with a spatula.
   11. With a scalpel, cut the frame into the dimensions and geometry appropriate for the available opening in the microscope stage. Dimensions of 1.5 (length) x 1.5 (width) x 0.5 (height) cm are suitable for most setups.
   12. Bring the smooth side (the bottom side that was in contact with the Petri dish) of the PDMS frame into contact with the active side of the surface where the Al₂O₃ film resides, and gently apply pressure to push the frame and surface against each other to make them adhere.
       NOTE: The adhesion between the PDMS frame and Al₂O₃ substrate is weak. The presence of air bubbles at the contact interface may cause de-attachment and, consequently, the leakage of the buffer and related content. The PDMS frame can be used several times if immediately after and before each use it is rinsed with isopropanol, followed by rinsing with DI water and blow-drying with nitrogen. The silanized Petri dish can also be reused.
5. Fill the observation chamber with Ca²⁺-HEPES buffer (see Table of Materials).
   NOTE: The surface should be used immediately after unsealing the package. Contact with air leads to adsorption of contaminants, which decreases the activity of the surface gradually. The chamber should be filled with buffer immediately after assembly. Do not fill the entire chamber volume to allow for addition of the rehydrated lipids in the subsequent step.
6. Place the chamber onto the confocal microscope stage. Transfer the rehydrated lipid material, now a suspension containing giant vesicles, into the chamber with a plastic Pasteur pipette (Figure 1A-1G).
7. Wait 10-20 min to let the vesicles adhere onto the substrate and spread across the surface (Figure 1H-1J).
   NOTE: The spreading starts immediately after deposition of lipids on the surface. The rate of spreading might slightly vary depending on the lipid composition, Al₂O₃ deposition technique (ADL, RF-sputtering, chemical vapor deposition, etc.), freshness of the substrate, and divalent cation concentration in the buffer. Ensure that buffer exchange is performed before rupturing of the spreading patches¹⁴.
8. After observing multiple lipid spreads, slowly remove the ambient buffer via an automatic pipette, such that only a thin buffer film remains on the bottom.
   NOTE: Rapid removal of buffer perturbs the lipid structures on the surface.
9. Proceed to the ambient buffer exchange by slowly filling the observation chamber with chelator-HEPES buffer (see Table of Materials) using an automatic pipette (Figure 1K).
   NOTE: Abrupt addition of buffer perturbs the lipid structures on the surface.
10. This final step yields dynamic nanotubular networks, formed as a result of the chelator-induced depinning and retraction of the DLBM to the MLV⁴ (Figure 1L-1Y).

4. Microscopy Observation

1. Acquire the images with an inverted laser scanning confocal microscope using a 40X oil (1.3 NA) immersion objective with a scanning frequency of 400 Hz. Employ a white light laser source to excite the Texas Red DHPE at 595 nm. Collect the emission from 605 to 700 nm by using a hybrid photon detector.
   NOTE: Alternatively, an epi-fluorescence microscope can be used for imaging. Depending on the light sources available, select an appropriate lipid-dye conjugate.

Discussion

In the following discussion, the critical steps, possible modifications, and limitations of the protocol are described. The first critical step is the proper assembly of the observation chamber, given that the adhesion of the PDMS frame to the Al₂O₃ surface is intrinsically weak. In the case where the frame does not adhere to the substrate properly, the content will leak from the observation chamber and the experiment will come to a halt. The main factors that hinder proper sealing of the surface and frame are 1) a lack of thorough cleaning of the (re-used) PDMS frame and 2) air bubbles that occasionally get entrapped between frame and substrate. A newly prepared or thoroughly cleaned PDMS frame should be used. The frame should be rinsed before and after each use with isopropanol, followed by rinsing with DI water and blow-drying with nitrogen. The Al₂O₃ surfaces do not require any prior cleaning, since they are fabricated in a cleanroom environment and kept in sealed containers until use. Due to the amphoteric nature of Al₂O₃, it should not be exposed to strongly acidic or basic solutions. Other designs for the observation chamber can be employed, depending on accessibility of the individual setup. Important features of this chamber are free access to the liquid sample from the open top and the inertness of the frame material with respect to the used solutions and samples. The chamber dimensions are also a significant factor, as they should accommodate a volume from 0.5 to 1 mL. Since the surfaces used are typically standard-sized coverslips (24 x 60 mm), the volume of the chamber is mostly determined by the thickness of the frame. To our knowledge, spacers with the size and depth which can accommodate the sample volumes typically handled in this protocol are not commercially available. We therefore have dedicated a section in the protocol to details of the fabrication and assembly of a sample chamber frame.

The other critical step in this protocol is the buffer exchange. A challenge in this step is the timing needed to perform this exchange. The spreading of the MLV upon contact with the Al₂O₃ substrate is instant, and the continuous expansion of the DLBM leads to its rupturing, terminating the experiment (Figure 2A,B). Therefore, the spreading should be constantly monitored, and the buffer exchange must be performed in a timely manner. The exchange should not be performed too quickly after initialization of the spreading, in order to allow the membrane patches to reach an optimal size (100-200 µm in diameter). On the other hand, continuous adhesion on the surface causes high membrane tension, which leads to rupturing. Thus, all membrane patches eventually rupture if spreading is not interrupted. The timing of the rupturing differs for each patch, since it depends on the size and internal structure of the MLV and accessibility of the lipids therein. Hence, the moment of the exchange should be arranged to a timepoint at which the un-ruptured patches with optimal sizes represent a majority of the entire population. Another challenge in the buffer exchange step is the rate of removal and addition of the buffers. Performing this substitution too rapidly has a detrimental influence on the final membrane structures (Figure 2C-E). The excessive extraction of the Ca²⁺-HEPES buffer without leaving a thin liquid film on the substrate, results in dried and irreversibly deformed membrane patches (Figure 2C). Even if a proper amount of liquid is maintained on the surface, abrupt addition of the Chelator-HEPES buffer also causes perturbation of the membrane structures. Figure 2D,E shows the typical appearance of hydrodynamically disrupted membrane patches. The overall morphological disruption does not necessarily influence the dynamic properties of the final structures (i.e., the tubular rearrangements in remaining areas will still occur). However, it will become difficult to observe the material transformation on the deformed structures. For example, in Figure 2D, it would be difficult to determine the direction towards which MLV the DLBM retracts.

One possible modification of the protocol is the lipid composition used. The main focus has been on phospholipids that dominate the ER composition in mammals and yeast¹⁶ (e.g., phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylinositol (PI). The original experiments were performed using PC and PI mixtures⁴. In the results presented, a mixture of PC and DOPE and a derivative of PE was used. However, not all arbitrary lipid compositions have been found to create the tubular structures obtained through this protocol. A few of the other experimentally investigated lipid mixtures involve total heart extract, soy bean extract polar, E. coli extract polar, mixtures of PC with stearoyl-2-hydroxy-sn-glycero-3-phosphoinositol (Lyso-PI) in varying ratios, and mixtures of PC-PE-PI-Posphatidyl serine (PS) in varying ratios. Since tubular membrane structures possess high curvatures and require special arrangement of individual lipid molecules, it is expected that the observed phenomenon is lipid composition-specific.

Another modification applied in this protocol is the method for surface fabrication. Here, the ALD was used to fabricate the Al₂O₃ coated coverslips. This differs from the originally reported deposition method, reactive sputtering⁴. While this indicates that an alternative surface fabrication method can still lead to ER-like tubulation, one important limitation appears to be the specificity of the surface material. The mode of spreading and strength of adhesion is highly dependent on properties of the surface material, which influence factors such as electrostatic interactions, wettability, hydrophobicity, and roughness of the surface. Al₂O₃ surfaces provide optimal adhesion strength, and lipid films can both attach strongly enough to spread as a double lipid bilayer membrane and detach to form tubular networks upon removal of Ca²⁺ ions. We previously tested the same experiment with SiO₂, in which the multilamellar vesicles spread as a double lipid bilayer membrane, but no tubular network formation was observed upon addition of chelators¹⁷. De-attachment and tube formation are observed only on Al₂O₃ or plasma etched Al¹⁸. Our investigations revealed that the contributing parameter leading to such a phenomenon was the zeta potential of the surfaces, for which Al and Al₂O₃ were close to zero (mV) and SiO₂ significantly negative. The zeta potential of borosilicate is similar to SiO₂¹⁹; therefore, adhesion of lipid films on borosilicate is equally strong and irreversible. In fact, multilamellar lipid reservoir contact with borosilicate surfaces typically leads to immediate rupture and formation of single lipid bilayers²⁰. The Al₂O₃ surfaces required for this protocol are not readily or commercially available. They can, however, be custom-ordered from specialty glass and substrate manufacturers. Access to cleanroom facilities with thin-film fabrication equipment is highly recommended.

The other existing bottom-up methods to fabricate ER-like tubular networks^2,10 involve proteins as well as input of chemical energy (e.g., GTP and ATP). Rapoport and colleagues² reported the formation of ER-networks on glass coverslips in vitro by mixing the membrane-bending proteins present in ER, with phospholipids and GTP. The work by Bachand et al.¹⁰ shows how such dynamic tubular networks can be created by using molecular motors and ATP as the energy source. This protocol presented does not require membrane proteins or hydrolysis of organic compounds for energy. The only essential components are the solid substrate and the phospholipids. Purification and extraction of proteins are not required. This protocol provides, in terms of simplicity of the constitutive molecules, the most basic ER model.

With this basic, lipid-based ER model established, building up complexity by adding ER-associated components is of interest, since it enables investigation of individual impacts on the system. Similar to the actual ER networks, tubes in the model are dynamic. The conjugation to and migration of the labeled membrane proteins, or fluorescent particles throughout the tubular network, may give information about the direction of membrane movement. Encapsulation and monitoring of the fluorescent liquids inside the DLBM and tubes during the transformation and a possible mapping of the intratubular content transport may serve as another focus. Finally, a transition from the 2D ER model resulting from this protocol towards a 3D smooth ER model may be adopted through encapsulation of the networks in hydrogel architectures.

Materials

Name	Company	Catalog Number	Comments
Pear-shape flask 10 mL	Lenz Laborglasinstrumente	3.0314.13	In which the lipid mixture is prepared
Hamilton 5 mL glass syringe (P/N)	Hamilton	P/N81520	For transfer of the chloroform to beaker
Custom large hub needle Gauge 22 S	Hamilton	7748-18	Removable needle for syringe specified in row 3
Hamilton 250 µL glass syringe	Hamilton	7639-01	Used for transfer of lipids in chloroform to the flask
Large hub Gauge 22 S	Hamilton	7780-03	Removable needle for syringe specified  in row 5
Hamilton 50 µL glass syringe	Hamilton	7637-01	Used for transfer of fluorophore-conjugated lipids to the flask
Small hub Gauge 22 S	Hamilton	7770-01	Removable needle for syringe specified in row 7
Chloroform anhydrous (≥99%)	Sigma-Aldrich	288306	Used to complete the lipid mixture to a total of 300 µL
Soy L-α Phosphatidyl choline lipid (Soy PC)	Avanti Polar Lipids Inc	441601	phospholipid species contributing to 69% of the total composition/mixture
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)	Avanti Polar Lipids Inc	850725	phospholipid species contributing to 30% of the lipid composition/mixture
L-α Phosphatidyl inositol lipid (Soy PI)	Avanti Polar Lipids Inc	840044	alterative phospholipid species contributing to 30% of the lipid composition/mixture (from the original article Bilal and Gözen, Biomaterials Science, 2017)
Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine,triethylammonium salt (Texas Red DHPE)	Invitrogen (Thermo Fisher Scientific)	T1395MP	Fluorescent-lipid conjugate, 1% of the lipid composition/mixture
Digital Dry Baths/Block Heaters	Thermo Fischer	88870006	To warm glycerol in order to decrease its viscosity
Glycerol for molecular biology (≥99%)	Sigma Life Science	G5516	For lipid preparation
PBS buffer  (pH=7.8); ingredients below in rows 17-21			Used to prepare the lipid suspension
TRIZMA base, primary standard and buffer (≥99%)	Sigma Life Science	T1503	Used to prepare PBS buffer
Potassium phosphate tribasic, reagent grade (≥98%) (K3PO4)	Sigma-Aldrich	P5629	PBS buffer ingredient
Magnesium sulfate heptahydrate, BioUltra (≥99,5%) KT (MgSO47H2O)	Sigma Life Science	63138	PBS buffer ingredient
Potassium phosphate monobasic, anhydrous, free flowing, Redi-Dri, ACS (KH2PO4)	Sigma-Aldrich	795488	PBS buffer ingredient
Ethylenediaminetetraacetic acid disodium salt dihydrate ACS reagent, 99.0-101.0% (Na2EDTA)	Sigma-Aldrich	E4884	PBS and Chelator-HEPES buffer ingredient
Ultrasonic cleaner USC-TH	VWR	142-0084	Ultrasonication of rehydrated lipids
Rotary evaporator  -  Büchi rotary evaporator Model R-200	Sigma	Z626797	For evaporation of chloroform
Pressure meter - Vacuum regulator IRV-100	SMC	IRV10/20	For controlling the pressure value during lipid dehydration
HEPES-buffer (pH=7.8); ingredients below in rows 26-27			Used for rehydration of lipids. Content: 10 mM HEPES with 100 m NaCl diluted in ultrapure deionized water
HEPES ≥99.5% (titration)	Sigma Life Science	H3375	HEPES-buffer ingredient
Sodium chloride for molecular biology, DNase, RNase, and protease, none detected, ≥98% (titration) (NaCl)	Sigma Life Science	S3014	HEPES-buffer ingredient
Calcium-HEPES buffer (pH=7.8); effective ingredient below in row 29			Used for spreading of lipids. Content: 10 mM HEPES, 100 mM NaCl, 4 mM CaCl2 diluted in ultrapure deionized water
Calcium chloride anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0% (CaCl2)	Sigma Life Science	C5670	To prepare Calcium-HEPES buffer
Chelator-HEPES buffer (pH=7.8); effective ingredient below in row 31			Used to promote the formation of tubular networks.  Content: 10 mM HEPES, 100 mM NaCl, 10 mM EDTA and 7 mM BAPTA diluted in ultrapure deionized water
1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrasodium salt ≥95% (HPLC) (BAPTA-Na4)	Sigma Life Science	14513	Chelator-HEPES buffer ingredient
Sodium Hydroxide	Sigma	30620	Basic solution used to adjust the pH of the buffers
pH meter accumet™ AE150 pH	Fisher Scientific	1544693	Used to measure the pH of all buffers
Glass petri dish	VWR	HECH41042012	6 cm, used for making the PDMS sheet
Potassium hydroxide ACS reagent, ≥85%, pellets (KOH)	Sigma-Aldrich	221473	To make the KOH solution for cleaning glass petri dish for the fabrication of the PDMS sheet
Isopropanol prima ren 99.5%	Antibac AS	600079	KOH solution ingredient
Heating and drying oven - venticell	MMM Medcenter Einrichtungen GmbH	MC000714	For drying of the glass petri dish after silanization and to cure PDMS
Dichlorodimethylsilane ≥99.5%	Sigma-Aldrich	440272	Used for silanization of glass petri dish in which PDMS sheet is prepared
Vacuum pump	Cole-Parmer	EW-79202-05	Connected to desiccator
Sylgard 184 silicone elastomer curing agent	Dow corning	24236-10	Kit to make PDMS solution
Sylgard 184 Silicone elastomer base
Disposable scalpel	Swann-Morton	11798343	Used to cut the PDMS
Cover slips	Menzel -Gläser	MEZ102460	24x60 mm. Used to deposit thin film of Al2O3
Atomic layer deposition system	Beneq	TFS200 (model number)	Atomic Layer deposition system used to deposit thin film of Al2O3 in microscope cover glass
Ellipsometer	J.A. Woollan Co.	Alpha-SE (model name)	System used to charcaterize the thickness of the film deposited on glass surface
Laser scanning confocal  microscope	Leica Microsystems	Leica TCS SP8 X	Microscope used for visualization of the experiment
Objective 40x, 1.3 NA	Leica Microsystems	1550635	Used for visualization of the experiment
White light laser source	Leica Microsystems	Leica TCS SP8 X	For excitation of the membrane fluorophore